(R)-(+)-Pantoprazole(CAS: 142706-18-1)

Regulatory guidelines for (R)-(+)-Pantoprazole (CAS: 142706-18-1) include the Classification, Labelling, and Packaging (CLP) Directive under the GHS, REACH regulations, and FDA/EPA related requirements. Manufacturers must ensure that the compound is classified as a pharmaceutical substance and comply with the relevant safety, environmental, and health regulations in their country of operation.

Alternatives to (R)-(+)-Pantoprazole (CAS: 142706-18-1) in synthesis include use of (S)-(-)-Pantoprazole or other proton pump inhibitors like omeprazole. Common alternative reagents include 2-chloroethylbenzene and 2,3-dihydrobenzimidazole, which are used in the preparation of various proton pump inhibitors.

The market and research trends for (R)-(+)-Pantoprazole (CAS: 142706-18-1) are shifting towards more cost-effective and sustainable production methods. There is also an increasing focus on developing new proton pump inhibitors with improved efficacy and reduced side effects. The research is exploring novel synthetic routes and optimizing existing ones for better yield and purity.

Waste containing (R)-(+)-Pantoprazole (CAS: 142706-18-1) should be collected in appropriate containers and stored in a secure, well-ventilated area. For disposal, it is recommended to incinerate the waste or use professional waste disposal services that comply with environmental regulations. Proper personal protective equipment and safety protocols should be followed to ensure safety during handling and disposal processes.